Supernus Pharmaceuticals Inc (SUPN)
34.48
-0.28
(-0.81%)
USD |
NASDAQ |
Nov 05, 11:41
Supernus Pharmaceuticals Price to Book Value: 1.984 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.001 |
| November 01, 2024 | 1.955 |
| October 31, 2024 | 1.961 |
| October 30, 2024 | 2.007 |
| October 29, 2024 | 1.979 |
| October 28, 2024 | 1.966 |
| October 25, 2024 | 1.953 |
| October 24, 2024 | 1.945 |
| October 23, 2024 | 1.949 |
| October 22, 2024 | 1.940 |
| October 21, 2024 | 1.938 |
| October 18, 2024 | 1.988 |
| October 17, 2024 | 1.948 |
| October 16, 2024 | 1.956 |
| October 15, 2024 | 1.929 |
| October 14, 2024 | 1.895 |
| October 11, 2024 | 1.899 |
| October 10, 2024 | 1.835 |
| October 09, 2024 | 1.864 |
| October 08, 2024 | 1.870 |
| October 07, 2024 | 1.845 |
| October 04, 2024 | 1.843 |
| October 03, 2024 | 1.848 |
| October 02, 2024 | 1.851 |
| October 01, 2024 | 1.842 |
| Date | Value |
|---|---|
| September 30, 2024 | 1.794 |
| September 27, 2024 | 1.770 |
| September 26, 2024 | 1.771 |
| September 25, 2024 | 1.723 |
| September 24, 2024 | 1.759 |
| September 23, 2024 | 1.808 |
| September 20, 2024 | 1.831 |
| September 19, 2024 | 1.849 |
| September 18, 2024 | 1.832 |
| September 17, 2024 | 1.826 |
| September 16, 2024 | 1.812 |
| September 13, 2024 | 1.790 |
| September 12, 2024 | 1.778 |
| September 11, 2024 | 1.789 |
| September 10, 2024 | 1.928 |
| September 09, 2024 | 1.952 |
| September 06, 2024 | 1.948 |
| September 05, 2024 | 1.979 |
| September 04, 2024 | 2.014 |
| September 03, 2024 | 1.998 |
| August 30, 2024 | 2.024 |
| August 29, 2024 | 2.014 |
| August 28, 2024 | 1.994 |
| August 27, 2024 | 2.009 |
| August 26, 2024 | 2.007 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.275
Minimum
Mar 18 2020
2.742
Maximum
Nov 05 2019
1.918
Average
1.914
Median
Aug 07 2023
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals Inc | 4.730 |
| Regeneron Pharmaceuticals Inc | 3.110 |
| United Therapeutics Corp | 2.783 |
| Ligand Pharmaceuticals Inc | 2.592 |
| Myomo Inc | 12.09 |
Price to Book Value Related Metrics
| PE Ratio | 384.64 |
| PS Ratio | 3.027 |
| Price to Free Cash Flow | 12.35 |
| Price | 34.48 |
| Earnings Yield | 0.26% |
| Market Cap | 1.900B |
| Operating PE Ratio | 46.93 |
| Normalized PE Ratio | 117.35 |